Low doses interferon-alpha in the treatment of high-risk cutaneous melanoma. Melanoma Cooperative Group

Ann Oncol. 2000 Apr;11(4):487-90. doi: 10.1023/a:1008375418507.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Disease-Free Survival
  • Humans
  • Interferon-alpha / therapeutic use*
  • Lymphatic Metastasis
  • Male
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Risk Factors
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology

Substances

  • Antineoplastic Agents
  • Interferon-alpha